Lei Qi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lei Qi has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Liang Wang
Shandong Univ, Qilu Hosp, Dept Orthopaed Surg, Jinan, Shandong, Peoples R China
4 shared publicationsMu Li
Qilu Hospital of Shandong University
3 shared publicationsYunpeng Jiang
Qilu Hospital of Shandong University
3 shared publicationsChao Li
Department of Orthopaedic Surgery Qilu Hospital of Shandong University Jinan Shandong China
2 shared publicationsCun Gao
Department of Thoracic Surgery, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China
2 shared publications- Hui Tian
Shandong Key Laboratory of Digital Diagnosis and Treatment of Thoracic Oncology, Shandong Engineering Research Center of Intelligent Surgery, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China
2 shared publications
Latest Publications
- Open Access
- 9 July 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1388868
Gene signatures of copper metabolism related genes may predict prognosis and immunity status in Ewing’s sarcoma
Background: Cuproptosis is copper-induced cell death. Copper metabolism related genes (CMRGs) were demonstrated that used to assess the prognosis out of tumors. In the study, CMRGs were tested for their effect on TME cell infiltration in Ewing’s sarcoma (ES).Methods: The GEO and ICGC databases provided the mRNA expression profiles and clinical features for downloading. In the GSE17674 dataset, 22prognostic-related copper metabolism related genes (PR-CMRGs) was identified by using univariate regression analysis. Subsequently, in order to compare the survival rates of groups with high and low expression of these PR-CMRGs,Kaplan-Meier analysis was implemented. Additionally, correlations among them were examined. The study employed functional enrichment analysis to investigate probable underlying pathways, while GSVA was applied to evaluate enriched pathways in the ES (Expression Set). Through an unsupervised clustering algorithm, samples were classified into two clusters, revealing significant differences in survival rates and levels of immune infiltration.Results: Using Lasso and step regression methods, five genes (TFRC, SORD, SLC11A2, FKBP4, and AANAT) were selected as risk signatures. According to the Kaplan-Meier survival analysis, the high-risk group had considerably lower survival rates than the low-risk group(p=6.013e-09). The area under the curve (AUC) values for the receiver operating characteristic (ROC) curve were 0.876, 0.883, and 0.979 for 1, 3, and 5 years, respectively. The risk model was further validated in additional datasets, namely GSE63155, GSE63156, and the ICGC datasets. To aid in outcome prediction, a nomogram was developed that incorporated risk levels and clinical features. This nomogram’s performance was effectively validated through calibration curves.Additionally, the study evaluated the variations in immune infiltration across different risk groups, as well as high-expression and low-expression groups. Importantly, several drugs were identified that displayed sensitivity, offering potential therapeutic options for ES.Conclusion: The findings above strongly indicate that CMRGs play crucial roles in predicting prognosis and immune status in ES.
- 9 July 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1388868
Open AccessGene signatures of copper metabolism related genes may predict prognosis and immunity status in Ewing’s sarcoma
Background: Cuproptosis is copper-induced cell death. Copper metabolism related genes (CMRGs) were demonstrated that used to assess the prognosis out of tumors. In the study, CMRGs were tested for their effect on TME cell infiltration in Ewing’s sarcoma (ES).Methods: The GEO and ICGC databases provided the mRNA expression profiles and clinical features for downloading. In the GSE17674 dataset, 22prognostic-related copper metabolism related genes (PR-CMRGs) was identified by using univariate regression analysis. Subsequently, in order to compare the survival rates of groups with high and low expression of these PR-CMRGs,Kaplan-Meier analysis was implemented. Additionally, correlations among them were examined. The study employed functional enrichment analysis to investigate probable underlying pathways, while GSVA was applied to evaluate enriched pathways in the ES (Expression Set). Through an unsupervised clustering algorithm, samples were classified into two clusters, revealing significant differences in survival rates and levels of immune infiltration.Results: Using Lasso and step regression methods, five genes (TFRC, SORD, SLC11A2, FKBP4, and AANAT) were selected as risk signatures. According to the Kaplan-Meier survival analysis, the high-risk group had considerably lower survival rates than the low-risk group(p=6.013e-09). The area under the curve (AUC) values for the receiver operating characteristic (ROC) curve were 0.876, 0.883, and 0.979 for 1, 3, and 5 years, respectively. The risk model was further validated in additional datasets, namely GSE63155, GSE63156, and the ICGC datasets. To aid in outcome prediction, a nomogram was developed that incorporated risk levels and clinical features. This nomogram’s performance was effectively validated through calibration curves.Additionally, the study evaluated the variations in immune infiltration across different risk groups, as well as high-expression and low-expression groups. Importantly, several drugs were identified that displayed sensitivity, offering potential therapeutic options for ES.Conclusion: The findings above strongly indicate that CMRGs play crucial roles in predicting prognosis and immune status in ES.
- Open Access
- 3 January 2023
- Published by Wiley in Orthopaedic Surgery
- Vol. 15 (3) , 695-703
Comparison of Clinical Outcomes and Muscle Invasiveness between Unilateral Biportal Endoscopic Discectomy and Percutaneous Endoscopic Interlaminar Discectomy for Lumbar Disc Herniation at L5/S1 Level
Objective: Both unilateral biportal endoscopic discectomy (UBED) and percutaneous endoscopic interlaminar discectomy (PEID) could achieve favorable outcomes for lumbar disc herniation (LDH). There are limited studies comparing the two different methods of endoscopic discectomy. The objective was to comprehensively compare the clinical outcome and muscle invasiveness of UBED and PEID for the treatment of LDH at L5/S1 level with at least 1‐year follow‐up.Methods: The retrospective cohort study enrolled 106 LDH patients of L5/S1 level from January 2018 to December 2020. There were 51 patients who underwent UBED (22 males and 29 females, 43.8 ± 14.2 years old) and 55 patients underwent PEID (28 males and 27 females, 42.3 ± 13.8 years old). Clinical outcomes and surgical invasiveness were compared between the two groups for at least 1 year follow‐up. Clinical outcomes included visual analogue scale (VAS) scores, Oswestry Disability Index (ODI), complications, recurrence of LDH, intraoperative anesthesia time, operative time, number of intraoperative fluoroscopies, and postoperative length of stay. Surgical invasiveness was evaluated with serum CPK level and change rate of lean multifidus cross‐sectional area (LMCSA). Independent‐sample t test and paired sample t test were used to compare continuous data. Chi‐square test and Fisher's precision probability tests were used to analyze the categorical data.Results: Both groups achieved favorable clinical outcomes at the last follow‐up, including VAS and ODI (all Ps vs 2.4), postoperative length of stay (2.1 vs 2.0 days), postoperative complications (5.9% vs 3.6%), there were also no significant difference. The serum CPK level and change rate of LMCSA for UBED was higher than PEID at postoperative 1st day. At the last follow‐up, there was no significant difference in the change rate of LMCSA between the two groups (P = 0.096).Conclusions: Both UBED and PEID could achieve favorable clinical outcomes for the treatment of L5/S1 LDH. Despite UBED is more invasive, the radiological manifestation of paraspinal muscle invasiveness was equal at last follow‐up with at least 1 year. UBED is a safe and innovative alternative choice for treatment of LDH at L5/S1 level.
- 3 January 2023
- Published by Wiley in Orthopaedic Surgery
- Vol. 15 (3) , 695-703
Open AccessComparison of Clinical Outcomes and Muscle Invasiveness between Unilateral Biportal Endoscopic Discectomy and Percutaneous Endoscopic Interlaminar Discectomy for Lumbar Disc Herniation at L5/S1 Level
Objective: Both unilateral biportal endoscopic discectomy (UBED) and percutaneous endoscopic interlaminar discectomy (PEID) could achieve favorable outcomes for lumbar disc herniation (LDH). There are limited studies comparing the two different methods of endoscopic discectomy. The objective was to comprehensively compare the clinical outcome and muscle invasiveness of UBED and PEID for the treatment of LDH at L5/S1 level with at least 1‐year follow‐up.Methods: The retrospective cohort study enrolled 106 LDH patients of L5/S1 level from January 2018 to December 2020. There were 51 patients who underwent UBED (22 males and 29 females, 43.8 ± 14.2 years old) and 55 patients underwent PEID (28 males and 27 females, 42.3 ± 13.8 years old). Clinical outcomes and surgical invasiveness were compared between the two groups for at least 1 year follow‐up. Clinical outcomes included visual analogue scale (VAS) scores, Oswestry Disability Index (ODI), complications, recurrence of LDH, intraoperative anesthesia time, operative time, number of intraoperative fluoroscopies, and postoperative length of stay. Surgical invasiveness was evaluated with serum CPK level and change rate of lean multifidus cross‐sectional area (LMCSA). Independent‐sample t test and paired sample t test were used to compare continuous data. Chi‐square test and Fisher's precision probability tests were used to analyze the categorical data.Results: Both groups achieved favorable clinical outcomes at the last follow‐up, including VAS and ODI (all Ps vs 2.4), postoperative length of stay (2.1 vs 2.0 days), postoperative complications (5.9% vs 3.6%), there were also no significant difference. The serum CPK level and change rate of LMCSA for UBED was higher than PEID at postoperative 1st day. At the last follow‐up, there was no significant difference in the change rate of LMCSA between the two groups (P = 0.096).Conclusions: Both UBED and PEID could achieve favorable clinical outcomes for the treatment of L5/S1 LDH. Despite UBED is more invasive, the radiological manifestation of paraspinal muscle invasiveness was equal at last follow‐up with at least 1 year. UBED is a safe and innovative alternative choice for treatment of LDH at L5/S1 level.
- Open Access
- 1 January 2022
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 15, 13-22
Sciatica-Related Spinal Imbalance in Lumbar Disc Herniation Patients: Radiological Characteristics and Recovery Following Endoscopic Discectomy
Background: Sciatica-related spinal imbalance could be observed in lumbar disc herniation (LDH) patients. However, their characteristics and recovery process remained unclear. The purpose was to analyze the radiological characteristics of spinal imbalance related to sciatica and recovery following endoscopic discectomy. Methods: The records of LDH patients with sciatica and spinal imbalance receiving endoscopic discectomy were retrospectively reviewed. The patients were divided to Group A (sagittal imbalance), Group B (coronal imbalance) and Group C (sagittal and coronal imbalance). The whole-spine x-ray was performed at pre-operation, immediately post-operation, 3-month and 6-month follow-up and related radiological parameters were measured. Results: A total of 110 LDH patients (18.3%) presented with spinal imbalance were included and there were 31 patients in Group A, 38 patients in Group B and 41 patients in Group C. In this study, 77.2% of the coronal imbalance patients present with trunk shifted to contralateral side of disc herniation and 65.3% of the sagittal imbalance patients present with forward trunk. Most patients present mild and moderate sagittal and coronal imbalance. The magnitude of sagittal and coronal imbalance in Group C was significantly more severe than that of Group A and Group B. Most patients (≥ 75%) acquired spinal balance immediately after surgery. The sagittal imbalance improved better than coronal imbalance and single plane imbalance improved better than biplane imbalance. At the postoperative 6-month follow-up, all patients recovered to normal sagittal and coronal balance. Conclusion: Sciatica-related spinal imbalance occurs in 18.3% of the LDH patients receiving endoscopic discectomy. Different subgroups of spinal imbalance present different characteristics. Spontaneous correction of the spinal imbalance could be achieved when sciatica was relieved immediately after surgery and well maintained during follow-up.
- 1 January 2022
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 15, 13-22
Open AccessSciatica-Related Spinal Imbalance in Lumbar Disc Herniation Patients: Radiological Characteristics and Recovery Following Endoscopic Discectomy
Background: Sciatica-related spinal imbalance could be observed in lumbar disc herniation (LDH) patients. However, their characteristics and recovery process remained unclear. The purpose was to analyze the radiological characteristics of spinal imbalance related to sciatica and recovery following endoscopic discectomy. Methods: The records of LDH patients with sciatica and spinal imbalance receiving endoscopic discectomy were retrospectively reviewed. The patients were divided to Group A (sagittal imbalance), Group B (coronal imbalance) and Group C (sagittal and coronal imbalance). The whole-spine x-ray was performed at pre-operation, immediately post-operation, 3-month and 6-month follow-up and related radiological parameters were measured. Results: A total of 110 LDH patients (18.3%) presented with spinal imbalance were included and there were 31 patients in Group A, 38 patients in Group B and 41 patients in Group C. In this study, 77.2% of the coronal imbalance patients present with trunk shifted to contralateral side of disc herniation and 65.3% of the sagittal imbalance patients present with forward trunk. Most patients present mild and moderate sagittal and coronal imbalance. The magnitude of sagittal and coronal imbalance in Group C was significantly more severe than that of Group A and Group B. Most patients (≥ 75%) acquired spinal balance immediately after surgery. The sagittal imbalance improved better than coronal imbalance and single plane imbalance improved better than biplane imbalance. At the postoperative 6-month follow-up, all patients recovered to normal sagittal and coronal balance. Conclusion: Sciatica-related spinal imbalance occurs in 18.3% of the LDH patients receiving endoscopic discectomy. Different subgroups of spinal imbalance present different characteristics. Spontaneous correction of the spinal imbalance could be achieved when sciatica was relieved immediately after surgery and well maintained during follow-up.
- Open Access
- 12 August 2021
- Published by Springer Nature in Molecular Medicine
- Vol. 27 (1) , 1-6
The role and mechanism of long non-coding RNA H19 in stem cell osteogenic differentiation
Background: In recent years, H19, as one of the most well-known long non-coding RNA, has been reported to play important roles in many biological and physiological processes. H19 has been identified to regulate the osteogenic differentiation of various stem cells in many studies. However, the detailed role and regulation mechanism of H19 was not consistent in the reported studies.Main body of the manuscript: In this review article we summarized the effect and mechanism of lncRNA H19 on osteogenic differentiation of various stem cells reported in the published literatures. The role and mechanism of H19, H19 expression changes, effect of H19 on cell proliferation in osteogenic differentiation were respectively reviewed.Conclusions: An increasing number of studies have provided evidence that H19 play its role in the regulation of stem cell osteogenic differentiation by different mechanisms. Most of the studies favored the positive regulatory effect of H19 through lncRNA-miRNA pathway. The function and underlying mechanisms by which H19 contributes to osteogenic differentiation require further investigation.
- 12 August 2021
- Published by Springer Nature in Molecular Medicine
- Vol. 27 (1) , 1-6
Open AccessThe role and mechanism of long non-coding RNA H19 in stem cell osteogenic differentiation
Background: In recent years, H19, as one of the most well-known long non-coding RNA, has been reported to play important roles in many biological and physiological processes. H19 has been identified to regulate the osteogenic differentiation of various stem cells in many studies. However, the detailed role and regulation mechanism of H19 was not consistent in the reported studies.Main body of the manuscript: In this review article we summarized the effect and mechanism of lncRNA H19 on osteogenic differentiation of various stem cells reported in the published literatures. The role and mechanism of H19, H19 expression changes, effect of H19 on cell proliferation in osteogenic differentiation were respectively reviewed.Conclusions: An increasing number of studies have provided evidence that H19 play its role in the regulation of stem cell osteogenic differentiation by different mechanisms. Most of the studies favored the positive regulatory effect of H19 through lncRNA-miRNA pathway. The function and underlying mechanisms by which H19 contributes to osteogenic differentiation require further investigation.
- Open Access
- 8 September 2020
- Published by Springer Nature in Research Square
The Treatment and Prophylaxis Usage Profile of Intravenous Vancomycin Medication in Orthopedics
Background: Despite vancomycin has been widely used in orthopedics, the details of vancomycin usage in orthopedics remains unknown. The purpose of the study was to evaluate the usage profile of intravenous vancomycin medication in orthopedics.Methods: The medical records of inpatients receiving intravenous vancomycin medication from January 2015 to December 2019 in a single center of orthopedics department were retrospectively reviewed. The gender, age, diagnosis, surgical information, microbiological data, duration of vancomycin medication were collected. The related data were analyzed and compared between subgroups.Results: A total of 258 cases receiving intravenous vancomycin medication (≥3 days) were enrolled. The mean age was 57.3 years. There were 141 cases in treatment and 117 in Prophylaxis group. The mean duration of vancomycin medication was 11.2 days. The duration was longer in Treatment than Prophylaxis group (14.8 versus 6.9 days, PConclusion: Taken together, our research firstly revealed the treatment and prophylaxis usage profile of intravenous vancomycin medication in orthopedics. It provides the different purposes, main causes, bacteriological data and medication duration for treatment and prophylaxis vancomycin usage in orthopedics.
- 8 September 2020
- Published by Springer Nature in Research Square
Open AccessThe Treatment and Prophylaxis Usage Profile of Intravenous Vancomycin Medication in Orthopedics
Background: Despite vancomycin has been widely used in orthopedics, the details of vancomycin usage in orthopedics remains unknown. The purpose of the study was to evaluate the usage profile of intravenous vancomycin medication in orthopedics.Methods: The medical records of inpatients receiving intravenous vancomycin medication from January 2015 to December 2019 in a single center of orthopedics department were retrospectively reviewed. The gender, age, diagnosis, surgical information, microbiological data, duration of vancomycin medication were collected. The related data were analyzed and compared between subgroups.Results: A total of 258 cases receiving intravenous vancomycin medication (≥3 days) were enrolled. The mean age was 57.3 years. There were 141 cases in treatment and 117 in Prophylaxis group. The mean duration of vancomycin medication was 11.2 days. The duration was longer in Treatment than Prophylaxis group (14.8 versus 6.9 days, PConclusion: Taken together, our research firstly revealed the treatment and prophylaxis usage profile of intravenous vancomycin medication in orthopedics. It provides the different purposes, main causes, bacteriological data and medication duration for treatment and prophylaxis vancomycin usage in orthopedics.
- Open Access
- 21 May 2020
- Published by Springer Nature in Research Square
The treatment and prophylaxis usage profile of intravenous vancomycin medication in orthopedics
Background Despite vancomycin has been widely used in orthopedics, the details of vancomycin usage in orthopedics remains unknown. The purpose of the study was to evaluate the usage profile of intravenous vancomycin medication in orthopedics. Methods The medical records of inpatients receiving intravenous vancomycin medication from January 2015 to December 2019 in a single center of orthopedics department were retrospectively reviewed. The gender, age, diagnosis, surgical information, microbiological data, duration of vancomycin medication were collected. The related data were analyzed and compared between subgroups. Results A total of 258 cases receiving intravenous vancomycin medication (≥ 3 days) were enrolled. The mean age was 57.3 years. There were 141 cases in treatment and 117 in Prophylaxis group. The mean duration of vancomycin medication was 11.2 days. The duration was longer in Treatment than Prophylaxis group (14.8 versus 6.9 days, P < 0.05). The main reasons for treatment were PJI after TKA (46.7%) and THA (18.2%) in Joint subgroup and SSI after spine surgery (51.5%) for Spine subgroup. For prophylaxis usage, the main reasons were postoperative clinical suspicious infection. The bacteria responsible for infections in Treatment group were S. epidermidis (34.6%), S. aureus (31.8%), other Staphylococcus (12.1%), MRSA (7.5%), Streptococcus (7.5%), Enterococcus faecalis (3.7%) and Bacillus (2.8%). Conclusion Taken together, our research firstly revealed the treatment and prophylaxis usage profile of intravenous vancomycin medication in orthopedics. It provides the different purposes, main causes, bacteriological data and medication duration for treatment and prophylaxis vancomycin usage in orthopedics.
- 21 May 2020
- Published by Springer Nature in Research Square
Open AccessThe treatment and prophylaxis usage profile of intravenous vancomycin medication in orthopedics
Background Despite vancomycin has been widely used in orthopedics, the details of vancomycin usage in orthopedics remains unknown. The purpose of the study was to evaluate the usage profile of intravenous vancomycin medication in orthopedics. Methods The medical records of inpatients receiving intravenous vancomycin medication from January 2015 to December 2019 in a single center of orthopedics department were retrospectively reviewed. The gender, age, diagnosis, surgical information, microbiological data, duration of vancomycin medication were collected. The related data were analyzed and compared between subgroups. Results A total of 258 cases receiving intravenous vancomycin medication (≥ 3 days) were enrolled. The mean age was 57.3 years. There were 141 cases in treatment and 117 in Prophylaxis group. The mean duration of vancomycin medication was 11.2 days. The duration was longer in Treatment than Prophylaxis group (14.8 versus 6.9 days, P < 0.05). The main reasons for treatment were PJI after TKA (46.7%) and THA (18.2%) in Joint subgroup and SSI after spine surgery (51.5%) for Spine subgroup. For prophylaxis usage, the main reasons were postoperative clinical suspicious infection. The bacteria responsible for infections in Treatment group were S. epidermidis (34.6%), S. aureus (31.8%), other Staphylococcus (12.1%), MRSA (7.5%), Streptococcus (7.5%), Enterococcus faecalis (3.7%) and Bacillus (2.8%). Conclusion Taken together, our research firstly revealed the treatment and prophylaxis usage profile of intravenous vancomycin medication in orthopedics. It provides the different purposes, main causes, bacteriological data and medication duration for treatment and prophylaxis vancomycin usage in orthopedics.
- 1 June 2019
- Published by Elsevier in World Neurosurgery
- Vol. 126, 593-600
Postoperative Progression of Cervical Ossification of Posterior Longitudinal Ligament: A Systematic Review
- 1 June 2019
- Published by Elsevier in World Neurosurgery
- Vol. 126, 593-600
Postoperative Progression of Cervical Ossification of Posterior Longitudinal Ligament: A Systematic Review
- Open Access
- 25 July 2017
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (4) , 4325-4330
Potential use of microRNA-200c as a prognostic marker in non-small cell lung cancer
MicroRNAs (miRNAs/miRs) are a class of small, highly conserved non‑coding RNAs that can serve either oncogenic or tumor‑suppressive roles in a wide variety of tumors. miR‑200c is a member of the miR‑200 family whose specific role in non‑small cell lung cancer (NSCLC) has not yet been elucidated. The purpose of the present study was to detect the expression level of miR‑200c in NSCLC, and to analyze its association with clinicopathological factors and patient prognosis. The present study determined the expression levels of miR‑200c in 110 tumor samples collected from patients diagnosed with NSCLC who underwent complete tumor resection with regional lymph node dissection, as assessed by reverse transcription‑quantitative polymerase chain reaction. The association between the expression level of miR‑200c and clinicopathological features and patient prognosis was also analyzed. The results showed that miR‑200c overexpression was detected in 66 of the 110 cases and was significantly associated with positive lymph node metastasis (P<0.001). Univariate survival analysis demonstrated that high miR‑200c expression, positive lymph node metastasis and advanced Tumor‑Node‑Metastasis (TNM) classification stage significantly predicted decreased 5‑year disease‑free survival rates (all P<0.05) and poor 5‑year overall survival rates (all P<0.01), respectively. The results of multivariate Cox regression analysis showed that TNM stage and miR‑200c expression retained its significance as an independent prognostic factor for unfavorable 5‑year disease‑free survival rates (P<0.05) and poor 5‑year overall survival rates (P<0.01). The present findings suggest that miR‑200c overexpression is significantly associated with poor survival rates in NSCLC and that miR‑200c could play an oncogenic role. miR‑200c may have clinical potential as a promising prognostic predictor for patients with NSCLC.
- 25 July 2017
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (4) , 4325-4330
Open AccessPotential use of microRNA-200c as a prognostic marker in non-small cell lung cancer
MicroRNAs (miRNAs/miRs) are a class of small, highly conserved non‑coding RNAs that can serve either oncogenic or tumor‑suppressive roles in a wide variety of tumors. miR‑200c is a member of the miR‑200 family whose specific role in non‑small cell lung cancer (NSCLC) has not yet been elucidated. The purpose of the present study was to detect the expression level of miR‑200c in NSCLC, and to analyze its association with clinicopathological factors and patient prognosis. The present study determined the expression levels of miR‑200c in 110 tumor samples collected from patients diagnosed with NSCLC who underwent complete tumor resection with regional lymph node dissection, as assessed by reverse transcription‑quantitative polymerase chain reaction. The association between the expression level of miR‑200c and clinicopathological features and patient prognosis was also analyzed. The results showed that miR‑200c overexpression was detected in 66 of the 110 cases and was significantly associated with positive lymph node metastasis (P<0.001). Univariate survival analysis demonstrated that high miR‑200c expression, positive lymph node metastasis and advanced Tumor‑Node‑Metastasis (TNM) classification stage significantly predicted decreased 5‑year disease‑free survival rates (all P<0.05) and poor 5‑year overall survival rates (all P<0.01), respectively. The results of multivariate Cox regression analysis showed that TNM stage and miR‑200c expression retained its significance as an independent prognostic factor for unfavorable 5‑year disease‑free survival rates (P<0.05) and poor 5‑year overall survival rates (P<0.01). The present findings suggest that miR‑200c overexpression is significantly associated with poor survival rates in NSCLC and that miR‑200c could play an oncogenic role. miR‑200c may have clinical potential as a promising prognostic predictor for patients with NSCLC.
- Open Access
- 11 February 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (2) , e88032
TFIIB-Related Factor 2 Over Expression Is a Prognosis Marker for Early-Stage Non-Small Cell Lung Cancer Correlated with Tumor Angiogenesis
The aim of this study was to examine BRF2 expression in patients with non-small cell lung cancer (NSCLC) and explore the relationship of BRF2 protein with clinicopathologic factors, tumor angiogenesis and prognosis. Both BRF2 protein and intratumoral microvessels were examined by immunohistochemical staining in 107 non-small cell lung cancer patients. Intratumoral m icrovessel density (MVD) was measured by counting CD-34 positive immunostained endothelial cells. Western blot and RT-PCR analyses were utilized to investigate the BRF2 expression status in tissues A notably higher level of BRF2 expression was found in NSCLC tissues at protein levels. In addition, univariate and multivariate analysis demonstrated that BRF2 protein over-expression and high MVD were significantly associated with tumor relapse. Although BRF2 overexpression and high MVD indicated poor 5-year overall survival (p = 0.004 and p = 0.019, respectively), multivariate analysis demonstrated that only BRF2 overexpression was an independent prognostic factor for unfavorable overall survival (P = 0.021). BRF2 is a promising biomarker to identify individuals with poor prognostic potential and a possible target for anti-angiogenic therapy for patients with early-stage NSCLC.
- 11 February 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (2) , e88032
Open AccessTFIIB-Related Factor 2 Over Expression Is a Prognosis Marker for Early-Stage Non-Small Cell Lung Cancer Correlated with Tumor Angiogenesis
The aim of this study was to examine BRF2 expression in patients with non-small cell lung cancer (NSCLC) and explore the relationship of BRF2 protein with clinicopathologic factors, tumor angiogenesis and prognosis. Both BRF2 protein and intratumoral microvessels were examined by immunohistochemical staining in 107 non-small cell lung cancer patients. Intratumoral m icrovessel density (MVD) was measured by counting CD-34 positive immunostained endothelial cells. Western blot and RT-PCR analyses were utilized to investigate the BRF2 expression status in tissues A notably higher level of BRF2 expression was found in NSCLC tissues at protein levels. In addition, univariate and multivariate analysis demonstrated that BRF2 protein over-expression and high MVD were significantly associated with tumor relapse. Although BRF2 overexpression and high MVD indicated poor 5-year overall survival (p = 0.004 and p = 0.019, respectively), multivariate analysis demonstrated that only BRF2 overexpression was an independent prognostic factor for unfavorable overall survival (P = 0.021). BRF2 is a promising biomarker to identify individuals with poor prognostic potential and a possible target for anti-angiogenic therapy for patients with early-stage NSCLC.